Key result
IV endothelin-1 cuts splanchnic blood flow ~18% vs control, lowering renal flow and glucose production.
Why the study?
Does intravenous endothelin-1 alter splanchnic and renal blood flow and glucose production in healthy subjects?
Does intravenous endothelin-1 alter splanchnic and renal blood flow and glucose production in healthy subjects?
Minimal increases in circulating endothelin-1 significantly reduce splanchnic and renal blood flow and splanchnic glucose production in healthy humans.
Answers are grounded in this paper and cite their sources.
Minimal ET-1 elevations may impair regional perfusion and glucose output in health; hypothesis-generating for its role in disease states with higher levels.
The effect of minimal changes in circulating plasma endothelin-1 (ET-1) was studied in 12 healthy subjects receiving either 60 min of ET-1 (0.2 pmol.kg-1.min-1) or physiological saline intravenously. Blood was drawn from arterial, renal, and central hepatic vein catheters. Arterial ET-1-like immunoreactivity (ET-1-LI) increased from 4.7 +/- 0.4 (SE) to 8.6 +/- 1.0 pmol/l during ET-1 infusion. After 10 min, plasma ET-1-LI had increased to 6.12 +/- 0.29 pmol/l. For comparison the plasma ET-1-LI level was 12.9 +/- 4.2 pmol/in five patients with sepsis syndrome. Mean arterial blood pressure rose from 92 +/- 3 to 99 +/- 4 mmHg. Estimated splanchnic and renal blood flows fell by 18 +/- 5 and 10 +/- 3%, respectively, and splanchnic glucose production fell by 42 +/- 6% within 10 min of the ET-1 infusion and differed compared with corresponding control values. Only estimated splanchnic blood flow had increased 60 min after the ET-1 infusion. No change in splanchnic uptake of lactate or glycerol was seen. In conclusion, we suggest that circulating ET-1 with small or no demonstrable change in plasma concentration interferes with vasoactivity and splanchnic glycogenolyses in health and possibly pathophysiological conditions.
No takes yet. Share an insight, caveat, or question.
Ahlborg et al. (1995) studied Healthy (n=12). Endothelin-1 (ET-1) vs. Physiological saline was evaluated on Splanchnic blood flow, renal blood flow, and splanchnic glucose production. Intravenous infusion of endothelin-1 in healthy subjects reduced splanchnic blood flow by 18%, renal blood flow by 10%, and splanchnic glucose production by 42% compared with control.
Synapse has enriched 10 related papers. Consider them for comparative context: